Submit
Search
Submit
Menu

  • Information

  • References

  • Contents

  • [1]G. Ganeshpurkar, G. Rai and A.P. Jain: Medicinal mushrooms: Towards a new horizon. Pharmacogno Rev 4 (8), 127-135 (2010)

  • [2]G.M. Mueller and J.P. Schmit: Fungal biodiversity: what do we know? What can we predict?. Biodivers Conserv 16(1), 1-5. (2007)

  • [3]M. Blackwell: The Fungi: 1, 2, 3 … 5.1 million species? Am J Bot 98(3), 426-438 (2011)

  • [4]J. Zhong, B. Feng-Wu and Z.Wei (Editors) Biotechnology in China I: From Bioreaction to Bioseparation and Bioremediation. Springer Berlin Heidelberg ISBN 978-3-540-88415-6 (2009)

  • [5]J.J. Zhong and J.H Xiao: Secondary metabolites from higher fungi: discovery, bioactivity, and bioproduction. Adv Biochem Eng Biotechnol 113, 79–150 (2009)

  • [6]C. Manoharachary, K. Sridhar, R. Singh, A. Adholeya, T.S. Suryanarayanan, S. Rawat and B.N. Johri: Fungal biodiversity: distribution, conservation and prospecting of fungi from India. Curr Sci 89, 58–71 (2005)

  • [7]G.A. Strobel: Endophytes as sources of bioactive products. Microbe Infect 5, 535–544 (2003)

  • [8]E.L. Cooper: Drug Discovery, CAM and Natural Products. eCAM. Evid Based Complement Alternat Med 1(3), 215–217(2004)

  • [9]G. M. König, S. Kehraus, S. F. Seibert, A. Abdel-Lateff, and D. Müller D: Natural products from marine organisms and their associated microbes. Chembiochem 7, 229-238 (2006)

  • [10]J. Zhao, L. Zhou, J. Wang, T. Shan, L. Zhong, X. Liu, and X. Gao: Endophytic fungi for producing bioactive compounds originally from their host plants. Current Research, Technology and Education Topics in Applied Microbiology and Microbial Biotechnology 567-576 (2010)

  • [11]I.C.F.R. Ferreira, J.A. Vaz, M.H. Vasconcelos and A. Martins: Compounds from Wild Mushrooms with Antitumor Potential. Anti-Cancer Agents Med Chem 10(5), 424-436 (2010)

  • [12]J.J. Zhang, Y. Li, T. Zhou, D.P. Xu, P. Zhang, S. Li, and H.B. Li: Bioactivities and Health Benefits of Mushrooms Mainly from China. Molecules 21, 938 (2016)

  • [13]X. Xu, H. Yan, J. Chen, X. Zhang: Bioactive proteins from mushrooms. Biotechnol Adv 29, 667–674. (2011)

  • [14]K. Kino, A. Yamashita, K. Yamaoka, J. Watanabe, S. Tanaka, K. Ko, K. Shimizu and H. Tsunoo: Isolation and characterization of a new immunomodulatory protein, ling zhi-8 (LZ-8), from Ganoderma lucidium. J Biol Chem 264 (1), 472-478 (1989)

  • [15]W.H. Lin, CH. Hung CH, C.I. Hsu and J.Y Lin: Dimerization of the N-terminal Amphipathic a-Helix Domain ofthe Fungal Immunomodulatory Protein from Ganoderma tsugae(Fip-gts) Defined by a Yeast Two-hybrid System and Site-directed Mutagenesis. J Biol Chem 272 (32), 20044-20048 (1997)

  • [16]X.W. Zhou, M. Xie, F. Hong and Q.Z. Li: Genomic Cloning and Characterization of a FIP-gsi Gene Encoding a Fungal Immunomodulatory Protein from Ganoderma sinense Zhao et al (Aphyllophoromycet) Int J Med Mushrooms 11 (1), 77-86 (2009)

  • [17]M.Y. Wu, M. F. Hsu, Ch.Sh. Huang, H.Y. Fu, Ch. T. Huang, and Ch.Sh. Yang: A 2.0 Å Structure of GMI, a Member of the Fungal Immunomodulator y Protein Family from Ganoderma Microsporum. NSRRC Activity Report II 132(2007)

  • [18]J.L. Ko, C.I. Hsu, R.H. Li, C.J. Kao and J.Y. Lin. A new fungal immunomodulatory protein, FIP-fve isolated from the edible mushroom Flammulina velutipes and its complete amino acid sequence: Eur J Biochem,228, 244-249 (1995)

  • [19]H.C. Hsu, C.I. Hsu, R.H. Lin, C.L. Kao, and J.Y. Lin: Fip-vvo, A New Fungal Immunomodulatory Protein. J Biol Chem 323, 557-565 (1997)

  • [20]F. Sheu, P.J. Chien, A.L. Chien, Y.F. Chen and K.L. Chin: Isolation and characterization of an immunomodulatory protein (APP) from the Jew’s Ear mushroom Auricularia polytricha. Food Chem 87, 593-600 (2004)

  • [21]F. Sheu , P.J. Chien, K.Y. Hsieh, K.L. Chin, W.T. Huang, C.Y. Tsao, Y.F. Chen, H.CH. Cheng and H.H. Chang: Purification, cloning, and functional characterization of a novel immunomodulatory protein from Antroida camphorate (Bitter mushroom) that exhibits TLR2- dependent NF-kB activation and M1 polarization within murine macrophages. J. Agric Food Chem (57), 4130-4141(2009)

  • [22]F. Sheu, P.J. Chien, H.K. Wang, H.H. Chang, Y.T. Shyu: New protein PCiP from edible golden oyster mushroom (Pleurotus citrinopileatus) activating murine macrophages and splenocytes. J Sci Food Agr 87 (8), 1550-1558 (2007)

  • [23]HH. Chang, CH. Yeh and F. Sheu: A Novel Immunomodulatory Protein from Poria cocos Induces Toll-like Receptor 4-Dependent Activation within Mouse Peritoneal Macrophages. J Agric Food Chem 57 (14), 6129–6139 (2009)

  • [24]F. Li, H. Wen, Y. Zhang, M. Aa and X. Liu: Purification and characterization of a novel immunomodulatory protein from the medicinal mushroom Trametes versicolor. Sci China Life Sci 54, 379-385 (2011)

  • [25]F. Li, H. Wen, X. Liu, F. Zhou and G. Chen: Gene cloning and recombinant expression of a novel fungal immunomodulatory protein from Trametes versicolor. Protein Expr Purif 82, 339–344 (2012)

  • [26]S.Y. Li, L.J. Shi, Y. Ding, Y. Nie and X.M: Tang. Identification and functional characterization of a novel fungal immunomodulatory protein from Postia placenta. Food Chem Toxicol 64-70, 64-70 (2015)

  • [27]J.W. Lin, S.Y. Guan, Z.W. Duan, Y.H. Shen, W.L. Fan, L.J. Chen, L. Zhang, L. Zhang and T.L. Li: Gene cloning of a novel fungal immunomodulatory protein from Chroogomphis rutilus and its expression in Pichia pastoris. J Chem Technol Biotechnol (2016)

  • [28]V. Pushparajah, A. Fatima, CH. Chong, T.Z. Gambule, C.J. Chan, S.T. Ng, C.S. Tan, S.Y Fung, S.S. Lee, N.H Tan and R.L. Lim: Characterisation of a New Fungal Immunomodulatory Protein from Tiger Milk mushroom, Lignosus rhinocerotis. Sci Rep 6, 1-16 (2016)

  • [29]S. Li, Y. Nie, Y. Ding, L. Shi and X. Tang: Recombinant Expression of a Novel Fungal Immunomodulatory Protein with Human Tumor Cell Antiproliferative Activity from Nectria haematococca. Int J Mol Sci 15, 17751-17764 (2014)

  • [30]H.Y. Yap, Y.H. Chooi, M. Firdaus-Raih, S.Y. Fung, S.T. Ng, C.S. Tan and N.H. Tan: The genome of the Tiger Milk mushroom, Lignosus rhinocerotis, provides insights into the genetic. BMC Genomics 15, 635 (2014)

  • [31]Murasugi A, S. Tanaka, N. Komiyama, N. Iwata, K. Kino, H. Tsunoo and S. Sakuma: Molecular Cloning of a cDNA and a Gene Encoding an Immunomodulatory Protein, Ling Zhi-8, from a Fungus Ganoderma lucidum. J Biol Chem 266 (4), 2486-2493(1991)

  • [32]S. Tanaka, K. Ko, K. Kino, K. Tsuchiya, A. Yamashita, A. Murasugi, S. Sakuma and H. Tsunoo. Complete Amino Acid Sequence of an Immunomodulatory Protein, Ling Zhi-8 (LZ-8) J Biol Chem 264(28) (1989)

  • [33]X.F. Wang, K.Q. Su, T.W. Bao, W.R. Cong, Y.F. Chen, Q.Z. Li and X.W. Zhou. Immunomodulatory effects of fungal proteins. Cur Top Nutraceut 10 (1), 1-12 (2012)

  • [34]S.L. Baldauf and J.D. Palmer: Animals and fungi are each other’s closest relatives: congruent evidence from multiple proteins. Proc Natl Acad Sci USA 90, 11558–11562 (1993)

  • [35]P.O. Wainright, G. Hinkle, M.L. Sogin and S.K. Stickel. Monophyletic origins of the metazoa: an evolutionary link with fungi. Science 260, 340–342 (1993)

  • [36]A.M. Calvo, R.A. Wilson, J.W. Bok and N.P. Keller: Relationship between secondary metabolism and fungal development. Microbiol Mol Biol Rev 66, 447–459 (2002)

  • [37]O.M. Bayram and G.H. Braus: Coordination of secondary metabolism and development in fungi: the velvet family of regulatory proteins. FEMS Microbiol Rev 36, 1–24 (2012)

  • [38]H.S. Park and J.H. Yu: Genetic control of asexual sporulation in filamentous fungi. Curr Opin Microbiol 15, 669–677 (2012)

  • [39]Y.L. Ahmed, J. Gerke, J. H.S. Park, O. Bayram, P. Neumann, M. Ni, A. Dickmanns, S.C. Kim, J.H. Yu, G.H. Braus and R. Ficne: The Velvet Family of Fungal Regulators Contains a DNA-Binding Domain Structurally Similar to NF-kB. PLOS Biol 11(12), e1001750 (2013)

  • [40]M. Christmann, T. Schmaler, C. Gordon, X. Huang and Ö. Bayram, J. Schinke, S. Stumpf, W. Dubiel and G. H. Braus: Control of multicellular development by the physically interacting deneddylases DEN1/DenA and COP9 signalosome. PLoS Genet 9, e1003275 (2013)

  • [41]G J Yu, Y.L. Yin, W.H Yu, W. Liu, Y.X. Jin, A. Shrestha, Q. Yang, X.D. Ye and H. Sun: Proteome Exploration to Provide a Resource for the Investigation of Ganoderma lucidum. PLOS One 10(3): e0119439 (2015)

  • [42]T. Gerngross: Advances in the production of human therapeutic proteins in yeasts and filamentous fungi. Nat Biotechnol 22(11), 1409-1414 (2004)

  • [43]Q.Z. Li, X.F. Wang and X.W. Zhou: Recent status and prospects of the fungal immunomodulatory protein family. Crit Rev Biotec, 31 (4), 365-375 (2011)

  • [44]P.H. Wang, C.I. Hsu, S.C. Tang, Y.L. Huang, J.Y. Lin and J.L. Ko: Fungal immunomodulatory protein from Flammulina velutipes induces interferon-gamma production through p38 mitogen-activated protein kinase signaling pathway. J Agric Food Chem 52, 2721-2725 (2004)

  • [45]WR. Cong, H. Xu, Y. Liu, QZ. Li, W. Li, and XW. Zhou: Production and functional characterization of a novel fungal immunomodulatory protein FIP-SN15 shuffled from two genes of Ganoderma species. Appl Microbiol Biotechno 98, 5967-5975 (2014)

  • [46]J.W. Lin, L.X. Hao, G.X. Xu, F. Sun, F. Gao, R. Zhang and L.X. Liu: Molecular cloning and recombinant expression of a gene encoding a fungal immunomodulatory protein from Ganoderma lucidum in Pichia pastoris. World J Microbiol Biotechnol 25, 383-390 (2009)

  • [47]M. Rai, G. Tidke and S. Wasser: Therapeutic potential of mushrooms. Nat Prod Radiance 4(4), 246-257 (2005)

  • [48]N.P. Keller, G. Turner, and J.W. Bennett: Fungal secondary metabolism - From biochemistry to genomics. Nature Rev Microbiol 3, 937-947 (2005)

  • [49]B. Patwardhan and M. Gautam: Botanical immunodrugs: Scope and opportunities. Drug Discov Today 10(7), 495-502 (2005)

  • [50]R. Russell, and M. Paterson: Ganoderma – A therapeutic fungal biofactory. Phytochem 67, 1985-2001 (2006)

  • [51]G.M. Halpern: Healing mushrooms: ancient wisdom for better health. SQUAREONE Publishers. New York. ISBN-13: 978-0-7570-0199-4. (2007)

  • [52]M.F. Moradali MF, H. Mostafavi, S. Ghods and G.A. Hedjaroude: Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi) Int Immunopharmacol 7, 701-724 (2007)

  • [53]X. Zhou, J. Lin, Y. Yin, J. Zhao, X, Sun and K. Tang: Ganodermataceae: Natural Products and Their Related Pharmacological Functions. Am J Chin Med 35(4), 559-574 (2007)

  • [54]B.S. Sanodiyaa, G.S. Thakura, R.K. Baghela, G.B.K.S. Prasadb and P.S. Bisen: Ganoderma lucidum: A Potent Pharmacological Macrofungus. Curr Pharm Biotechnol 10, 717-742 (2009)

  • [55]E. Guillamón, A. García-Lafuente, M. Lozano, M. D´Arrigo, M.A. Rostagno, A. Villares and J.A. Martínez: Edible mushrooms: Role in the prevention of cardiovascular diseases. Fitoterapia 81, 715-723 (2010)

  • [56]T. Walsh: Biopharmaceutical benchmarks 2014. Nat Biotechnol 32(10), 992-1000 (2014)

  • [57]J. Erjavec, J. Kos, M. Ravnikar, T. Dreo and J. Sabotic, J: Proteins of higher fungi – from forest to application. Trends Biotechnol 30(5), 259-273 (2012)

  • [58]S.A. Naz: A Review: “Health Benefits of Mushrooms”. Online International Interdisciplinary Research Journal. Special Issue 4, 285-291 (2014) ISSN 2249-9598.

  • [59]M. Haak-Frendscho, K. Kino, T. Sone, and P. Jardieu: Ling Zhi-8: A novel T cell mitogen induces cytokine production and upregulation of ICAM-1 expression. Cell Immunol 150, 101-113 (1993)

  • [60]C.M. Yeh, C.K. Yeh, X.Y. Hsu, Q.M. Luo and M.Y. Lin: Extracellular Expression of a Functional Recombinant Ganoderma lucidium Immunomodulatory Proteinby Bacillus subtilis and Lactococcuslactis. Appl Environ Microb 74 (4), 1039-1049 (2008)

  • [61]L.Y. Chiu, M.E. Hu, T.Y. Yang, I.L. Hsin, J.L. Ko, K.J. Tsai and G.T. Sheu: Immunomodulatory Protein from Ganoderma microsporum Induces Pro-Death Autophagy through Akt-mTOR-p70S6K Pathway Inhibition in Multidrug Resistant Lung Cancer Cells. PLOS ONE 10(5), 1-23 (2015)

  • [62]L. Huang, F. Sun, C. Liang, Y.X. He, R. Bao, L. Liu and CZ, Zhou: Crystal structure of LZ-8 from the medicinal fungus Ganoderma lucidum. Proteins 75, 524-527 (2008)

  • [63]L.G. van der Hem, J.A. van der Vliet, C.F. Bocken, K. Kino, A.J. Hoitsma and W.J. Tax: Ling Zhi-8: studies of a new immunomodulating agent. Transplant 60, 438-443 (1995)

  • [64]C.H. Liao, Y.M. Hsiao, C.P. Hsu, M.Y. Lin, J.C. Wang, Y.L. Huang, and J.L. Ko: Transcriptionally mediated inhibition of telomerase of fungal immunomodulatory protein from Ganoderma tsugae in A549 human lung adenocarcinoma cell line. Mol Carcinog 45, 220-229 (2006)

  • [65]C.H. Liao, Y.M. Hsiao, G.T. Sheu, J.T. Chang, P.H. Wang, M.F. Wu, G.J. Shieh and J.L. Ko. Nuclear translocation of telomerase reverse transcriptase and calcium signaling in repression of telomerase activity in human lung cancer cells by fungal immunomodulatory protein from Ganoderma tsugae. Biochem Pharmacol 74, 1541-1554 (2007)

  • [66]K. Ahmadi and M. Riazipour: T-2 Toxin Regulated Ganoderma lucidum Induced Cytokine Release. Am J Immunol 4(1), 8-13 (2008)

  • [67]S. Ipcho, T. Sundelin, G. Erbs, H.C. Kistler, M.A. Newman and S. Olsson: Fungal Innate Immunity Induced by Bacterial Microbe-Associated Molecular Patterns (MAMPs) G3 Genes Genomes Genetics 6,1585-1595 (2016)

  • [68]P.V. Jeurinka, C.L. Noguerab, H.F.J. Savelkoul, and H.J. Wichers: Immunomodulatory capacity of fungal proteins on the cytokine production of human peripheral blood mononuclear cells. Int Immunopharmacol 8, 1124-1133. (2008)

  • [69]H.Y. Hsu, Y.C. Kuan, T.Y. Lin, S.M. Tsao, J. Hsu, J.M. Li and F. Sheu: Reishi Protein LZ-8 Induces FOXP3+ Treg Expansion via a CD45-Dependent Signaling Pathway and Alleviates Acute Intestinal Inflammation in Mice. Hindawi Publishing Corporation, Evid Based Complem and Alternat Med 2013, 1-13. (2013)

  • [70]F. Han, Y. Liu, LQ. Guo, X.L. Zeng, Z.M. Liu, J.F. Lin: Heterologous expression of the immunomodulatory protein gene from Ganoderma sinense in the basidiomycete Coprinopsis cinerea. J ApplMicrobiol 109, 1838-1844 (2010)

  • [71]S. Bastiaan-Net, W. Chanput W, A. Hertz , RD. Zwittink , J.J. Mes and HJ. Wichers: Biochemical and functional characterization of recombinant fungal immunomodulatory proteins (rFIPs) Int Immunopharmacol 15, 167-175 (2013)

  • [72]HA. El Enshasy, R. Hatti-Kaul: Mushroom immunomodulators: unique molecules with unlimited applications. Trends Biotechnol 31(12), 668-677 (2013)

  • [73]Y.T. Lu, Y.C. Kuan, H.H. Chang, and F. Sheu: Molecular Cloning of a Poria cocos Protein That Activates Th1 Immune Response and Allays Th2 Cytokine and IgE Production in a Murine Atopic Dermatitis Model. J. Am Chem Soc 62, 2861-2871 (2014)

  • [74]L.A. Palomares, S. Estrada-Mondaca and O.T. Ramírez: Production of recombinant proteins: challenges and solutions. Methods Mol Biol 267:15-52 (2004)

  • [75]J.L. Ko, S.J. Lin, C.I. Hsu, C.L. Kao, and J.Y. Lin: Molecular cloning and expression of a fungal immunomodulatory protein, FIP-fve, from Flammulina velutipes. J Formos Med Assoc 96, 517–524. (1997)

  • [76]A.R. Lara: Producción de proteínas recombinantes en Escherichia coli. Rev Mex Ing Quim 10 (2), 209-223 (2011)

  • [77]G.J. Gopal and A. Kumar: Strategies for the Production of Recombinant Protein in Escherichia coli. Protein J 32, 419–425 (2013)

  • [78]G.L. Rosano and E.A. Ceccarelli: Recombinant protein expression in Escherichia coli: advances and challenges. Front. Microbiol 5, 1-17 (2014)

  • [79]X. Kong, J.Zhang, X. Han, P. Zhan, X, Dai, J. Liu, X. Zhang, I. Lee I and S.Liu: High-Yield Production in Escherichia coli of Fungal Immunomodulatory Protein Isolated from Flammulina velutipes and Its Bioactivity Assay in vivo. Int J Mol Sci 14, 2230-2241 (2013)

  • [80]Q. Li, X. Wang, Y. Chen, J. Lin and X. Zhou: Cytokines Expression Induced by Ganoderma sinensis Fungal Immunomodulatory Proteins (FIP-gsi) in Mouse Spleen Cells. Appl Biochem Biotechnol 162, 1403-1413 (2010)

  • [82]Promchai, R., B. Promdonkoy, S. Tanapongpipat, W. Visessanguan, L. Eurwilaichitr and P. Luxananil: A novel salt-inducible vector for efficient expression and secretion of heterologous proteins in Bacillus subtilis. J Biotechnol 222 86-93 (2016)

  • [83]Li, A. Anumanthan, X.G. Gao, K. Ilangovan, W. Suzara, N. Düzgüneş, and V. Renugopalakrishnan: Expression of Recombinant Proteins in Pichia pastoris. Appl Biochem Biotechnol 142, 105-124 (2007)

  • [84]M. Ahmad, M.Hirz, H. Pichler H and H. Schwab: Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production. Appl Microbiol Biotechnol 98, 5301-5317 (2014)

  • [85]J.W. Lin, J. Jia, Y.H. Shen, M. Zhong, L.J. Chen, H.G Li, H.Ma, Z.F. Guo, M.F Qi, L.X. Liu, and T.L. Li: Functional expression of FIP-fve, a fungal immunomodulatory protein from the edible mushroom Flammulina velutipes in Pichia pastoris GS115. J Biotech 168 (4), 527-533(2013)

  • [86]A.B. Maghodia, C. Geisler and D.L. Jarvis: Characterization of an Sf-rhabdovirus-negative Spodoptera frugiperda cell line as an alternative host for recombinant protein production in the baculovirus-insect cell system. Protein Expres Purif 122, 45-55 (2016)

  • [87]T.R. Jinn, C.M. Wu, W.C. Tu, J.L. Ko, J.T. and Tzen JT: Functional Expression of FIP-gts, a Fungal Immunomodulatory Protein from Ganoderma Tsugae in Sf21 Insect Cells. Biosci Biotech Bioch 70 (11), 2627-2634 (2006)

  • [88]T.Y. Wu, H.A. Chen, F.Y. Li, Lin C.T., C.M. Wu, F.C. Hsieh, J.T. Tzen, S.K. Hsieh, J.L. Ko and T.R. Jinn: High-Level Expression, Purification and Production of the Fungal Immunomodulatory Protein-Gts in Baculovirus-Infected Insect Larva. Appl Biochem Biotechnol 169, 976-989 (2013)

  • [89]C.M Wu, T.Y. Wu, S.S. Kao, J.L. Ko and T.R. Jinn. Expression and purification of a recombinant Fip-fve protein from Flammulina velutipes in baculovirus-infected insect cells. J Appl Microbiol, 104, 1354-1362 (2008)

  • [90]J.E. Stajich, S.K. Wilke, D. Ahrén, C.H, Au, B.W. Birren, M. Borodovsky, C. Burns, B. Canbäck, L.A. Casselton, C.K. Cheng CK, J. Deng, F.S. Dietrich, D.C. Fargo, M.L. Farman, A.C. Gathman, J. Goldberg, R. Guigó, P.J. Hoegger, J.B. Hooker, A. Huggins, T.Y. James, T. Kamada, S. Kilaru, C.Kodira, U.Kües, D. Kupfer, H.S. Kwan, A. Lomsadze, W.Li, W.W.Lilly, L.J. Ma, A.J. Mackey, G. Manning, F. Martin, H. Muraguchi, D.O. Natvig, H. Palmerini, M.A. Ramesh, C.J. Rehmeyer, B.A. Roe, N. Shenoy, ,M. Stanke, V. V. Ter-Hovhannisyan, A. Tunlid, R. Velagapudi, T.J. Vision, Q. Zeng, M.E. Zolan and P.J. Pukkila: Insights into evolution of multicellular fungi from the assembled chromosomes of the mushroom Coprinopsis cinerea (Coprinuscinereus) PNAS 107 (26), 11889-11894. (2010)

  • [91]Pukkila, P. Coprinopsis cinérea: Curr Biol 21 (16), R616-R617 (2011)

  • [92]J. Xu, M.C. Dolan, G. Medrano, C.L. Cramer and P.J. Weathers: Green factory: Plants as bioproduction platforms for recombinant proteins. Biotechnol Adv 30, 1171-1184 (2012)

  • [93]E. Egelkrout, V. Rajan, and J.A. Howard: Overproduction of recombinant proteins in plants: Plant Sci 184, 83– 101 (2012)

  • [94]Y.C. Kuo, C.C. Tan, J.T. Ku, W.C. Hsu, S.C. Su, C.A. Lu, and L.F. Huang: Improving Pharmaceutical Protein Production in Oryza sativa. Int J Mol Sci 14, 8719-8739 (2013)

  • [95]M. Merlin, E. Gecchele, S. Capaldi, M. Pezzotti and L. Avesani: Comparative Evaluation of Recombinant Protein Production in Different Biofactories: The Green Perspective. Bio Med Res Int 2014, 1-14 (2014)

  • [96]C.F.Su, I.C. Kuo, P.W. Chen, CH. Huang, S.V. Seow, K.Y. Chua, and S.M. Yu: Characterization of an immunomodulatory Der p 2-FIP-fve fusion protein produced in transformed rice suspension cell culture. Transgenic Res 21, 177–192 (2012)

  • [97]W.R. Cong, Y. Liu, Q.Z. L and X.W. Zhou: Cloning and analysis of a functional promoter of fungal immunomodulatory protein from Flammulina velutipes. Mol Biol Rep 41, 4381–4387 (2014)

  • [98]J.R. Swartz: Advances in Escherichia coli production of therapeutic proteins. Curr Opin Biotechnol 12,195-201 (2001)

  • [99]G. Potvin and Z. Zhang: Strategies for high-level recombinant protein expression in transgenic microalgae: A review. Biotechnol Adv 28, 910–918 (2010)

  • [100]N.A. Baeshen, M.N. Baeshen, A. Sheikh, R.S. Bora, M.M. Ahmed, H.A. Ramadan, K.S. Saini and E.M. Redwan: Cell factories for insulin production. Microb Cell Fact 13,141-149 (2014)

  • [101]S. Wildt and T.U. Gerngross: The humanization of n-glycosylation pathways in yeast. Nature Rev Microbiol 3,119-128 (2005)

  • [102]M. Bardor, C.Faveeuw, A.C. Fitchette, D. Gilbert, L. Galas, F. Trottein, L. Faye, and P. Lerouge: Immunoreactivity in mammals of two typical plant glyco-epitopes, core α(1,3)-fucose and core xylose. Glycobiology 13(6), 427-434 (2003)

  • [103]E.L. Decker and R. Reski: The moss bioreactor. Curr Opin Plant Biol 7, 166-170 (2004)

  • [104]L. Doron, N. Segal and M. Shapira: Transgene Expression in Microalgae. From Tools to Applications. Front Plant Sci 2, 505 (2016)

  • [105]M. Goodman: Pharmaceutical industry financial performance. Nat Rev Drug Discov 8, 927-928 (2009)

  • [106]V. Vijayalakshmia and M. Srividyab: A study on financial performance of pharmaceutical industry in India. J Manag Sci 4(3), 36-54 (2014)

  • [107]K.K. Devi and U. Maheswari: A Study on Financial Performance of Cipla ltd & Aurobindo Pharma ltd. A Comparative Analysis. J Progress Res Soc Sci 2(1), 36-39 (2015) ISSN: 2395-6283

  • [108]J.A. Stenken and A.J. Poschenrieder: Bioanalytical chemistry of cytokines – A review. Anal Chim Acta 853, 95-115 (2015)

  • [109]J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, DM. Parki, D. Forman and F. Bray: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer E359–E386 (2015)

  • [110]Y. Ding , S.V. Seow, CH. Huang, L.M.Liew, Y.C.Lim, I.C.Kuo and KY. Chua: Coadministration of the fungal immunomodulatory protein FIP-Fve and a tumour-associated antigen enhanced antitumour immunity. Immunology 128, e881–e894 (2009)

  • [111]A.M. Bodles-Brakhop and R. Draghia-Akli. DNA vaccination and gene therapy: optimization and delivery for cancer therapy. Expert Rev Vaccines 7,1085-1101 (2008)

  • [112]T.Y. Weng, M.C. Yen, C.T. Huang, J.J. Hung, Y.L. Chen, W.C. Chen, C.Y. Wang, J.Y. Chang, J. Y and M.D. Lai: DNA vaccine elicits an efficient antitumor response by targeting the mutant Kras in a transgenic mouse lung cancer model. Gene Ther 21,888-896 (2014)

  • [113]C.C. Lin, Y.L. Yu, C.C. Shih, K.J. Liu, K.L. Ou, L.Z. Hong, J.D. Chen and C.L. Chu: A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells. Cancer Immunol Immunother 60, 1019-1027 (2011)

  • [114]A.J. Levine: p53, the cellular gatekeeper for growth and division. Cell 88, 323-331 (1997)

  • [115]F. Toledo and G. Wahl: Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat. Rev. Cancer 6, 909-923 (2006)

  • [116]U.M. Moll and O. Petrenko: The MDM2-p53 Interaction. Mol Cancer Res 1(14), 1001-1008 (2003)

  • [117]S. Shangary and S. Wang:Targeting the MDM2-p53 Interaction for Cancer Therapy. Clin Cancer Res 14(17), 5318-5324 (2008)

  • [118]C.T. Wu, T.Y. Lin, H.Y. Hsu, F. Sheu, C.M. Ho and E.I. Chen: Ling Zhi-8 mediates p53-dependent growth arrest of lung cancer cells proliferation via the ribosomal protein S7-MDM2-p53 pathway. Carcinogenesis 32 (12), 1890-1896 (2011)

  • [119]C.H. Liao, Y.M. Hsiao, C.H. Lin, C.S. Yeh, J.C., Wang and C.H. Ni: Induction of premature senescence in human lung cancer by fungal immunomodulatory protein from Ganoderma tsugae. Food Chem Toxicol 46(5), 1851–1859 (2008)

  • [120]Ch. H. Lin, G.T. Sheu, Y.W. Lin, Ch.Sh. Yeh, Y.-H. Huang, Y.Ch. Lai, J.G. Chang and J.L. Ko: A new immunomodulatory protein from Ganoderma microsporum inhibits epidermal growth factor mediated migration and invasion in A549 lung cancer cells. Process Biochem 45, 1537-1542 (2010)

  • [121]Z. Lu, S. Ghosh, Z. Wang and T. Hunter: Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of β-catenin, and enhanced tumor cell invasion. Cancer Cell 4(6), 499-515 (2003)

  • [122]M.L. Jaramillo, M. Banville, C. Collins, B. Paul-Roc, L. Bourget and M. O’Connor-McCourt: Differential sensitivity of A549 non small lung carcinoma cell responses to epidermal growth factor receptor pathway inhibitors. Cancer Biol Ther 7(4), 557- 68 (2008)

  • [123]B.M. Chung, M. Dimri, M. George, A.L. Reddi, G. Chen, V. Band and H. Band, H: The role of cooperativity with Src in oncogenic transformation mediated by non-small cell lung cancer-associated EGF receptor mutants. Oncogene 28(16), 1821-32 (2009)

  • [124]Y. Takada, S. Singh and B.B. Aggarwal: Identification of a p65 peptide that selectively inhibits NF-κB activation induced by various inflammatory stimuli and its role in down-regulation of NF-κB mediated gene expression and up-regulation of apoptosis. J Biol Chem 279(15), 15096-15104 (2004)

  • [125]L.K. Mosavi, D.L. Minor and Z. Peng: Consensus-derived structural determinants of the ankyrin repeat motif. PNAS 99(25), 16029-16034 (2002)

  • [126]C.H. Lin, C.Y. Hsiao, Ch. Ou, Y.W. Lin, Y.L. Chiu, K. Lue, J.G. Chang, and J.L. Ko: GMI, a Ganoderma Immunomodulatory Protein, Down-regulates Tumor Necrosis Factor r-Induced Expression of Matrix Metalloproteinase 9 via NF-KB Pathway in Human Alveolar Epithelial A549 Cells. J Agric Food Chem 58, 12014–12021 (2010)

  • [127]M.T. Rosenfeldt and K.M. Ryan: The multiple roles of autophagy in cancer. Carcinogenesis 32, 955-963 (2011)

  • [128]I.L. Hsin, G.T. Sheu, M.S. Jan, H.L. Sun, T.Ch. Wu, L.Y. Chiu, K.H. Lue and J.L. Ko: Inhibition of lysosome degradation on autophagosome formation and responses to GMI, an immunomodulatory protein from Ganoderma microsporum. Br J Pharmaco 167,1287–1300 (2012)

  • [129]I.L. Hsin, Ch. Ou, M.F. Wu, M.Sh. Jan, Y.M. Hsiao, Ch. Lin, and J.L. Ko: GMI, an immunomodulatory protein from Ganoderma microsporum, potentiates cisplatin-induced apoptosis via autophagy in lung cancer cells. Mol Pharmaceutics 12 (5), 1534-1543 (2015)

  • [130]S. Mi, M. Lin, J. Brouwer-Visser, J. Heim, D. Smotkin, T.M. Hebert, M.J. Gunter, G.L. Goldberg, D. Zheng, and G.S. Huang: RNA-seq identification of RACGAP1 as a metastatic driver in uterine carcinosarcoma. Clin Cancer Res 22(18), 4676-86 (2016)

  • [131]Y. Chang, Y.M. Hsiao, M.F. Wu, Ch. Ou, Y.W. Lin, K.H. Lue and J.L. Ko: Interruption of Lung Cancer Cell Migration and Proliferation by Fungal Immunomodulatory Protein FIP-fve from Flammulina velutipes. J Agric Food Chem 61, 12044-12052. (2013)

  • [132]H. Xu, Y.Y. Kong, X. Chen, M.Y. Guo, X.H. Bai, Y.J. Lu, W. Li and X.W, Zhou: Recombinant FIP-gat, a Fungal Immunomodulatory Protein from Ganoderma atrum, Induces Growth Inhibition and Cell Death in Breast Cancer Cells. J Agric Food Chem 64, 2690−2698 (2016)

Article Metrics

  • Information

  • Download

  • Contents

Frontiers in Bioscience-Elite (FBE) is published by IMR Press from Volume 13 Issue 2 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

1 Jun 2017Review
Fungal immunomodulatory proteins in the context of biomedicine
Paula Tatiana Uribe-Echeverry 1, German Ariel Lopez-Gartner 2,*
Affiliations
Article Info

1 Health Faculty, University of Manizales, Street 9a # 19-03, Manizales, Colombia

2 Department, Natural Sciences Faculty, University of Caldas, Street 65 # 26-10, Manizales, Colombia

*Author to whom correspondence should be addressed.

 

Abstract

Fungi represent a large group of biodiverse microorganisms with potential applications ranging from industrial fields to the treatment for human diseases. A large number of pharmacologically active compounds including terpenoids, polysaccharides and proteins have been derived from these microorganisms. Fungal Immunomodulatory Proteins (FIPs) are a group of active compounds that are being considered for the treatment of asthma, allergy, autoimmune diseases and cancer. Here, we discuss the discovery, heterologous production bioactive mechanisms of action and their potential use in biomedicine.

Keywords

  • Fungal Immunomodulatory Proteins
  • FIPs
  • Recombinant Proteins
  • Fungal Bioactivity
  • Review

References